WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...

Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval ...

OneLegacy is partnering with Loma Linda University Medical Center, Keck USC Medical Center and Cedars Sinai Medical Center to provide NMP technology and save more lives. This technology offers an ...

OneLegacy, the nonprofit organ procurement organization serving Southern California, announced the launch of the first in-house Ex Vivo Lung Perfusion (EVLP) program at an organ procurement ...

New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...

PLYMOUTH, Mich., Feb. 20, 2026 /PRNewswire/ -- Orrum Clinical Analytics today announced a strategic partnership with LivaNova USA Inc. to connect LivaNova's Essenz™ Perfusion System to the analytics ...

ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

FUJIFILM Biosciences, announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 ...

Fed-batch gives you one data point per sample pull. Perfusion demands continuous, real-time process intelligence, and process analytical technology (PAT) is the only way to deliver it. As ...

Spectroscopy is enabling faster, non-invasive point-of-care diagnostics, supporting real-time clinical decision-making and ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.